We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cell Cycle Assay with Staining Reagents

By Biotechdaily staff writers
Posted on 01 Dec 2004
Cell cycle analysis is easier with a new assay that includes precombined staining regents, eliminating the need for complex reagent preparation following cell fixation.

The assay allows fast and easy examination of cell division phases in immunology, cancer drug discovery, and cell health profiling. More...
Called Cell Cycle, the assay provides detailed protocols for use with either individual tubes or nine-well microtiter plates, thus minimizing assay development time. The automated analysis capability displays results in both histogram and statistical formats. The assay was developed by Guava Technologies, Inc. (Hayward, CA, USA).

The assay uses the nuclear DNA stain propidium iodide (PI) to directly discriminate cells at different stages of the cell cycle. Incubation can be as short as only one hour. Accuracy and high user-to-user reproducibility of absolute cell counts are obtained directly as a standard feature without the need for reference beads.

"Cells in different stages of cell cycle express different genes and proteins. Hence, in addition to determining viability and apoptotic cell fractions, every experiment involving cell populations should be normalized for cell cycle,” explained Kim Mulcahy, director of product marketing at Guava Technologies.





Related Links:
Guava Technologies

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Aspiration System
VACUSAFE
New
Automated Urinalysis Solution
UN-9000
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.